Total planned funding: $79,718,817
Allocations
Countries/Regions
Central Asia Region | $79,718,817 |
Organizational Types
Own Agency | $26,414,149 |
Unknown | $19,141,387 |
University | $12,184,792 |
NGO | $8,356,993 |
Host Country Government Agency | $6,726,267 |
Private Contractor | $4,282,129 |
Multi-lateral Agency | $2,265,000 |
Other USG Agency | $181,100 |
Implementing Agency | $167,000 |
Program Areas
Prevention | $25,245,614 |
Management and Operations | $18,462,386 |
Governance and Systems | $17,167,820 |
Care | $9,606,187 |
Testing | $5,234,230 |
Treatment | $4,002,580 |
Budget Codes
HVMS: Management and Operations | $18,462,386 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $18,161,031 |
HBHC: Care: Adult Care and Support | $8,221,785 |
HLAB: Laboratory Infrastructure | $6,499,791 |
HVSI: Strategic Information | $5,491,031 |
HVCT: Testing: HIV Testing and Counseling | $5,234,230 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,204,478 |
OHSS: Health Systems Strengthening | $5,176,998 |
HTXS: Treatment: Adult Treatment | $3,976,560 |
HMBL: Biomedical Prevention: Blood Safety | $1,405,750 |
HVTB: Care: TB/HIV | $1,384,402 |
HMIN: Biomedical Prevention: Injection Safety | $474,355 |
HTXD: Treatment: ARV Drugs | $26,020 |
Top Partner Programs
Not Available:
$19,041,387
Countries/Regions
USG Aggregated Agencies:
$15,274,786
Countries/Regions
Central Asia Region
2011 | $5,099,999 |
2012 | $1,121,824 |
2015 | $4,926,674 |
2016 | $4,126,289 |
Columbia University:
$12,184,792
Countries/Regions
U.S. Centers for Disease Control and Prevention:
$6,221,704
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
2014 | $2,983,204 |
U.S. Agency for International Development:
$4,917,659
Countries/Regions
Central Asia Region
2013 | $2,538,500 |
2014 | $2,379,159 |